HOPE Center Study Finds Statin Adherence Associated with Lower Healthcare Costs and Use

(February 3, 2021)

College of Pharmacy and HOPE Center alumni DAVID RHYS AXON, PhD, MPharm, MS and TERRI WARHOLAK, PhD, RPh co-authored a new study in the Journal of Clinical Lipidology titled A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans. The researchers assessed statin adherence using over a one year period among a cohort of commercially insured patients in the United States. Findings showed that 61.9% of the eligible patients were adherent to the statin medication, which was associated with: fewer inpatient visits; lower outpatient, inpatient, and total costs; and lower per member per month total costs than nonadherence. Co-authors also include College of Pharmacy Health & Pharmaceutical Outcomes Program alumni Patrick Campbell, PhD and Chanadda Chinthammit, PhD , PharmD Program alumnus Seth Anderson, PharmD, MS, and HOPE Center affiliate Ann Taylor, MPH, MCHES.